Andrei Floroiu
2023
In 2023, Andrei Floroiu earned a total compensation of $1.9M as Former President and Chief Executive Officer at Biota Pharmaceuticals, a 48% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,917 |
|---|---|
| Option Awards | $801,895 |
| Salary | $568,333 |
| Stock Awards | $286,833 |
| Other | $10,866 |
| Total | $1,866,844 |
Floroiu received $801.9K in option awards, accounting for 43% of the total pay in 2023.
Floroiu also received $198.9K in non-equity incentive plan, $568.3K in salary, $286.8K in stock awards and $10.9K in other compensation.
Rankings
In 2023, Andrei Floroiu's compensation ranked 545th out of 2,338 executives tracked by ExecPay. In other words, Floroiu earned more than 76.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 545 out of 2,338 | 77th |
Division Manufacturing | 306 out of 1,259 | 76th |
Major group Chemicals And Allied Products | 213 out of 711 | 70th |
Industry group Drugs | 211 out of 682 | 69th |
Industry Biological Products, Except Diagnostic Substances | 73 out of 165 | 56th |
Source: SEC filing on April 29, 2024.
Floroiu's colleagues
We found two more compensation records of executives who worked with Andrei Floroiu at Biota Pharmaceuticals in 2023.